6ehv: Difference between revisions
Jump to navigation
Jump to search
m Protected "6ehv" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
==scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery== | |||
<StructureSection load='6ehv' size='340' side='right' caption='[[6ehv]], [[Resolution|resolution]] 2.54Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6ehv]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6EHV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6EHV FirstGlance]. <br> | |||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ehv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ehv OCA], [http://pdbe.org/6ehv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ehv RCSB], [http://www.ebi.ac.uk/pdbsum/6ehv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ehv ProSAT]</span></td></tr> | |||
[[ | </table> | ||
__TOC__ | |||
</StructureSection> | |||
[[Category: Hargreaves, D]] | [[Category: Hargreaves, D]] | ||
[[Category: Abvance]] | |||
[[Category: Immune system]] | |||
[[Category: Pistoia alliance]] | |||
[[Category: Scfv]] |
Revision as of 10:56, 8 November 2017
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discoveryscFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
Structural highlights
|
|